A Multicenter Phase II Study Evaluating BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Prior to Autologous Stem Cell Transplant for First and Second Chemosensitive Relapses in Patients With Follicular Lymphoma
Phase of Trial: Phase II
Latest Information Update: 26 Jun 2019
Price : $35 *
At a glance
- Drugs Bendamustine (Primary) ; Cytarabine; Etoposide; Melphalan
- Indications Follicular lymphoma
- Focus Therapeutic Use
- Acronyms BENEFIT
- 04 Jan 2019 Status changed from recruiting to discontinued.
- 03 Aug 2017 Planned primary completion date changed from 1 Jul 2019 to 1 Jul 2018.
- 21 Nov 2016 Planned End Date changed from 1 Jan 2020 to 1 Jan 2022.